Specialised Therapeutics Electronics Co., Ltd. (ST Asia) has exclusive rights to market and distribute Aplidin® in Australia, Singapore and 12 other South East Asian countries under the terms of an arrangement with European partner PharmaMar . "We look forward to working with our European partner PharmaMar to ensure this valuable multiple myeloma therapy is available as soon as possible to patients in key South East Asia regions, as well as in Australia and New Zealand," he said.